Gene · 84061
Papers1,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, synthesis, and biological evaluation of RIPK1-targeting PROTACs. | Mol Divers | 2026 | 40126738 | PubTator, text mining | PubMed |
| Evolution of proteolysis-targeting chimeras (PROTAC) technology to overcome challenges of antimicrobial resistance. | NPJ Antimicrob Resist | 2025 | 41345312 | PubTator, text mining | PubMed |
| Atypical Phenotype of Predominant Autoimmune Cytopenia and Impaired Perforin Expression in XMEN Syndrome. | J Immunol Res | 2025 | 41141376 | PubTator, text mining | PubMed |
| Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies. | Cureus | 2025 | 41018333 | PubTator, text mining | PubMed |
| Zebrafish models for congenital disorders of glycosylation (CDG): a systematic review. | Orphanet J Rare Dis | 2025 | 40993721 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| EBV-associated smooth muscle tumour: a clinicopathological and genetic study of nine cases revealing heterogeneous immune statuses and novel pathogenic mutations. | Histopathology | 2025 | 40955557 | PubTator, text mining | PubMed |
| Triaminophenaziniums as emerging theranostic agents showing light controlled imaging, cell death and siRNA delivery properties. | Bioorg Chem | 2025 | 40929797 | PubTator, text mining | PubMed |
| Downregulation of Mg2+ Efflux Protein CNNM3 Predicts Poor Prognosis but Enhances Ferroptosis Sensitivity in Kidney Renal Clear Cell Carcinoma via NCOA4-Mediated Ferritinophagy. | FASEB J | 2025 | 40824137 | PubTator, text mining | PubMed |
| Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2025 | 40809696 | PubTator, text mining | PubMed |
| Case Report: Pediatric CNS-isolated hemophagocytic lymphohistiocytosis secondary to uniparental disomy of PRF1 mutation. | Front Genet | 2025 | 40761310 | PubTator, text mining | PubMed |
| Design, synthesis, and activity evaluation of Asiatic acid derivatives as Survivin inhibitors. | Bioorg Med Chem Lett | 2025 | 40414314 | PubTator, text mining | PubMed |
| Effects of two different variants in the MAGT1 gene on B cell subsets, platelet function, and cell glycome composition. | Front Immunol | 2025 | 40170846 | PubTator, text mining | PubMed |
| Bioactive Inorganic Materials for Innervated Multi-Tissue Regeneration. | Adv Sci (Weinh) | 2025 | 40013907 | PubTator, text mining | PubMed |
| Unveiling the prognostic significance of RNA editing-related genes in colon cancer: evidence from bioinformatics and experiment. | Eur J Med Res | 2025 | 39940052 | PubTator, text mining | PubMed |
| Prevalence of pathogenic variants of inborn errors of immunity in critically ill children admitted to the pediatric intensive care unit for sepsis: A Moroccan cohort study. | Tunis Med | 2025 | 39812200 | PubTator, text mining | PubMed |
| xMEN: a modular toolkit for cross-lingual medical entity normalization. | JAMIA Open | 2025 | 39735785 | PubTator, text mining | PubMed |
| Pluripotent polysaccharide coordinated hydrogels remodel inflammation, neovascularization and reepithelization for efficient diabetic wound prohealing. | J Control Release | 2025 | 39549729 | PubTator, text mining | PubMed |
| Loss-of-function variant in MAGT1 leading to XMEN disease in a Colombian patient with a common variable immunodeficiency | Biomedica | 2024 | 39836832 | PubTator, text mining | PubMed |
| [Current and future medical treatment for endometriosis]. | Nihon Yakurigaku Zasshi | 2024 | 39496410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84061/papers?page=2